Prostate Cancer

Isoray, Inc. RICHLAND, Wash., June 21, 2022 (GLOBE NEWSWIRE) -- The growing body of information regarding Isoray, Inc.'s (NYSE American: ISR) Cesium-131 in treating prostate cancer was highlighted in two presentations at the just concluded American Brachytherapy Society's annual conference in Denver, Colorado. During the conference, the Prostate Snap Oral I scientific session included two abstracts that were presented by The Cesium Advisory Group. The group is comprised of five experienced physicians with extensive experience using Cesium-131 monotherapy for permanent prostate brachytherapy who came together to form the advisory group. Commenting on the presentations, Isoray CEO Lori Woods said, "Long-term outcomes have demonstrated the significance of Cesium-131 brachytherapy for prostate cancer treatment. These abstracts present valuable information for clinicians on achieving the best possible implant based on the recommendations of experienced Cesium-131 users. They l...

Lichen sclerosus is a skin condition that can increase your risk of cancer. It's not a type of cancer on its own, but treating this condition can help you prevent vulvar cancer. Lichen sclerosus causes symptoms like itching, pain, and patches that form on the skin around your genitals. Treatment for the condition typically involves strong corticosteroids. Read on to learn more about the link between lichen sclerosus and cancer. Lichen sclerosus is a chronic skin condition that mostly affects postmenopausal people. But lichen sclerosus can affect people of any gender and any age, especially people with vulvas. Lichen sclerosus is directly associated with an increased risk of vulvar cancer . Vulvar cancer is a type of skin cancer that forms around the genitals in areas like the labia or clitoris. Less than 1 percent of all cancers diagnosed in women each year are vulvar cancer. About 4 percent of women who have lichen sclerosus will develop vulvar cancer. This means that people with...

Small-cell lung cancer makes up approximately 15 percent of lung cancers in the United States. The strongest risk factor for this cancer is smoking tobacco. Small-cell lung cancer tends to be very aggressive and quickly spreads to other parts of the body. In a 2021 study, researchers found that by the time of diagnosis, the cancer spread from the lungs to the brain in about 10 to 20 percent of cases. During treatment, researchers found the cancer spread to the brain in about 50 to 80 percent of cases. Many people with small-cell lung cancer go into remission during their initial treatment. For the majority of people, small-cell lung cancer relapses within a year. The 5-year relative survival remains at 7 percent . Remission means signs and symptoms of your cancer have improved. If you achieve complete remission, all signs and symptoms of the cancer are gone. Read on to learn more about how long remission typically lasts and what factors influence remission length. Small-cell lung canc...

Patients with high degrees of obstruction may even develop urinary tract infections and bladder stones, said Dr Thiruchelvam Jegathesan, a consultant with Tan Tock Seng Hospital's Department of Urology. "The exact reason for BPH is not known but is postulated to be related to age and male hormones causing a proliferation of the prostate cells," he said. "Typically, BPH can happen after 50 years old and it becomes more prevalent with age." A study done in Singapore supports the age link that Dr Jegathesan mentioned. As the population ages, the incidence of local patients with moderate to severe BPH symptoms has been increasing – from 10 per cent in 1997 to 14 per cent in 2005, and 16.5 per cent in 2012. Greater awareness of BPH could have also led to a higher incidence rate recorded over the years, said Dr Fiona Wu, a consultant urologist with Aare Urocare. "Generally, more people are aware of the condition and seeking professional advice ea...

June 01, 2022 1 min watch Source/Disclosures Published by: Source: Healio Interviews Disclosures: Babaian reports no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . " data-action="subscribe...

Although ovarian carcinoid (OC) is a well-differentiated neuroendocrine tumor (NET) resembling those arising from the digestive system, there is no established nomenclature for this tumor. According to the 5 th WHO classification [1, 2], we can consider this case as a well-differentiated neuroendocrine tumor, Grade 1 (NET, G1) arising from an mature cystic teratoma, but the ICD-O coding is different between the two systems [1, 7]. From the limited data of primary OC, the prognosis is generally excellent, but relapse, metastasis, or even death had been reported [8,9,10,11,12,13,14]. Fortunately, this woman was surjected to a radical surgery and was in good condition at the current follow-up. Close follow-up, however, will continue for a long time. Therefore, we think it's necessary to develop the current OC classification, and we recommended it would be best to follow the 5 th WHO classification of tumors of the digestive system [1]. Considering clinical manifestations, most patie...

This transcript has been edited for clarity. I'm Dr Neil Skolnik. Today, I'm going to talk about the American Urologic Association's new guidelines on the management of lower urinary tract symptoms, also called LUTS, due to benign prostatic hyperplasia (BPH). BPH is common, occurring in about 60% of men over 60 years of age. BPH causes symptoms through two mechanisms. The first is hypertrophy, leading to resistance to urinary outflow and symptoms of hesitancy; difficulty starting a stream; and a slow, weak stream of urine. The second is increased smooth muscle tone of the urethra and bladder, which leads to symptoms like urgency, frequency, and nocturia. During initial evaluation, the guidelines recommend quantifying symptoms using an International Prostate Symptom Score, which can then be used to follow symptoms. Do a physical exam, examine the prostate, and obtain a urinalysis. A postvoid residual is considered optional. For mild symptoms, ...